ShareRoot Limited announced a third collaboration participant in the application of MediaConsent to medical research and healthcare settings with Cancer Trials Australia (CTA) joining the project. The MediaConsent Medical project now has three health or medical research related collaborators - St Vincent's Hospital, Melbourne, Neuroscience Trials Australia, and CTA, each a world-class major research and/or clinical provider in Australia. The collaboration will apply ShareRoot's MediaConsent platform as a tool that offers clinical researchers access to a variety of consented real world data and evidence, in one platform. The benefit of the MediaConsent platform in a healthcare setting may deliver: All data accessed via a single consent platform that puts the patient in control. No data is held within MediaConsent posing a significantly reduced data security risk. Ability to use data from patient's social media to understand a patient's lived experienced with an illness, condition or injury. A rich, vertically integrated diverse dataset that may offer new insight into causal relationships, attitudes, behaviours and outcomes. Compliant platform with new and emerging legislation and regulation regarding data ownership, data security and data privacy as well as existing codes of conduct, regulation and legislation that all healthcare providers and developers must adhere to.